本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ADC Therapeutics SA

4.13
-0.1600-3.73%
盤前4.130.00000.00%09:01 EDT
成交量:70.96萬
成交額:295.57萬
市值:4.63億
市盈率:-2.62
高:4.31
開:4.28
低:4.11
收:4.29
52周最高:4.74
52周最低:1.05
股本:1.12億
流通股本:9,224.08萬
量比:0.59
換手率:0.77%
股息:- -
股息率:- -
每股收益(TTM):-1.5758
每股收益(LYR):-1.6246
淨資產收益率:-705.53%
總資產收益率:-22.99%
市淨率:-2.32
市盈率(LYR):-2.54

資料載入中...

2022/12/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/14

SEC問詢函

CORRESP [Cover] - Correspondence
2022/09/14

SEC問詢函

CORRESP [Cover] - Correspondence
2022/06/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/17

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/03

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/06

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/18

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/18

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/18

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/11

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/25

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/12

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]